Gold Alexander M
SEC CIK 2026429 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MLYS | Mineralys Therapeutics, Inc. | Dir | 6,200 | — | $1.58M | 3 | 2025-11-11 | 2026-02-19 |
Most active insiders at MLYS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Catalys Pacific Fund, LP | 10% | — | $43.35M |
| 2 | Congleton Jon | CEO, Dir | — | $14.91M |
| 3 | Rodman David Malcom | Chief Medical Off | — | $14.41M |
| 4 | Shah Rajeev M. | Dir | $8.76M | — |
| 5 | Levy Adam Scott | CFO, Sec | — | $6.16M |
| 6 | Warren Eric | Chief Commercial Off | — | $3.30M |
| 7 | Gold Alexander M | Dir | — | $1.58M |
| 8 | Karydas Daphne | Dir | — | $925.6K |
| 9 | Slingsby Brian Taylor | Dir, 10% | — | — |
| 10 | DiRocco Derek | Dir | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-20 | 2026-02-19 | MLYS | Mineralys Therapeutics, Inc. | Gold Alexander M | Dir | A - Grant | $0.00 | +6,200 | 6,200 | New | $0 |
| DM | 2025-11-13 | 2025-11-11+ | MLYS | Mineralys Therapeutics, Inc. | Gold Alexander M | Dir | S - Sale+OE | $45.45 | -34.7K | 5,000 | -87% | -$1.58M |
| DM | 2025-11-13 | 2025-11-11+ | MLYS | Mineralys Therapeutics, Inc. | Gold Alexander M | Dir | M - OptEx | $10.92 | +34.7K | 15.0K | New | +$378.6K |
Purchase Sale Sale after option exercise All abbreviations